HELIX ACQUISITION CORP. HLXA 深 沪

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

During Men's Health Awareness Month, Medicus Pharma highlights advancements in prostate and skin cancer treatments. For advanced prostate cancer, the company is developing next-generation hormone deprivation therapies to reduce cardiovascular risks. In skin cancer, a dissolvable microneedle patch delivers chemotherapy directly to lesions, offering a non-invasive alternative to Mohs surgery. The company has expanded clinical trials for these innov...

11-24 13:00

OpenAI投资初创公司，旨在防范人工智能驱动的生物武器

　　ChatGPT 母公司 OpenAI 于周四宣布，将投资一家专注于防范 “不良行为者利用人工智能制造生物武器” 的初创公司。 　　该初创公司联合创始人汉努...

11-14 00:36

BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress

BBOT, a clinical-stage biopharma company focused on RAS and PI3Kα pathway malignancies, reported Q3 2025 financials with $468.3M cash runway, advancing three Phase 1 KRAS and PI3Kα inhibitors.近的数据读出预计2026年，任命新任CFO。季度R&D费用达到3510万美元，管理费用为1410万美元，总净亏损4470万美元。

11-12 21:05

Earnings Preview: ProFrac Holding

ProFrac Holding (NASDAQ:ACDC) is preparing to release its quarterly earnings on...

11-07 23:04

BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025

11-06 00:29

Astrotech Corporation Appoints Scott Bartley as Interim Chief Financial Officer

Astrotech Corporation has appointed Scott Bartley as Interim Chief Financial Officer, effective October 20, 2025. Bartley, a seasoned financial professional with over 20 years of experience, previously served as a financial consultant, CFO, and controller for various public and private companies. He holds certifications as a CPA and Certified Valuation Analyst, with degrees from the University of Texas at Austin. Astrotech Corporation, headquarte...

10-31 20:15

Helix Biopharma GAAP EPS of -$0.09

Helix Biopharma press release (OTCPK:HBPCF): FY GAAP EPS of -$0.09.  As at July 31, 2025, the Company’s cash reserves of $65,000 are insufficient to meet anticipated cash needs for working capital and...

10-30 05:49

Helix BioPharma Reports Fiscal 2025 Results and Strategic Developments

The latest announcement is out from Helix BioPharma ( ($TSE:HBP) ). Helix BioPh...

10-30 02:08

NVIDIA and US Manufacturing and Robotics Leaders Drive America's Reindustrialization With Physical AI

NVIDIA Omniverse for Manufacturing Leading U.S. manufacturers, software devel...

10-29 01:40

TD Cowen Maintains Buy on Helix Energy Solns Gr, Raises Price Target to $12

TD Cowen analyst James Schumm maintains Helix Energy Solns Gr (NYSE:HLX) with a Buy and raises the price target from $11 to $12.

10-25 00:48